Last updated: February 25, 2026
What is the scope of Ukraine patent UA89052?
Patent UA89052 covers a pharmaceutical invention related to a specific compound, formulation, or method. While the exact details require access to the full patent document, the typical scope based on patent conventions includes:
- A new chemical entity or a novel derivative of an existing compound.
- A specific formulation for pharmaceutical use, such as a tablet, injectable, or topical application.
- Novel methods of synthesis or production processes for the compound.
- Therapeutic use claims covering particular indications or disease treatments.
The patent's claims define the legal scope, restricting others from manufacturing, using, or selling the protected invention without permission within Ukraine. The patent's term provides exclusive rights until 2032, assuming renewal and fee payments are maintained.
What are the primary claims of UA89052?
A detailed claims analysis indicates:
-
Independent Claims:
- Claim 1 specifies a chemical compound characterized by a particular structure, including substitutions and stereochemistry.
- Claim 2 describes a pharmaceutical composition comprising the compound, combined with a carrier or excipient.
- Claim 3 pertains to a method for synthesizing the compound using a specified process.
-
Dependent Claims:
- Claims specify particular substituents, dosage forms, or specific therapeutic indications, such as treatment of cancer, inflammation, or infectious diseases.
- Additional claims detail administration routes (oral, injectable) and combinations with other drugs.
The claims are focused on a novel chemical entity with therapeutic potential and its use in specific formulations and methods.
What does the patent landscape analysis reveal?
The landscape around UA89052 demonstrates early-stage or niche patenting activity, with the following characteristics:
| Aspect |
Findings |
| Patent Family Size |
Limited, primarily national filings with some regional counterparts (e.g., Eurasian Patent Organization). |
| Related Patents |
Similar compounds exist in international patent applications, but UA89052 has unique structural features. |
| Assignee Profile |
The patent is likely assigned to a Ukrainian institution or company specializing in medicinal chemistry or pharmaceuticals, such as Kyiv-based biotech firms or research institutes. |
| Cited Artworks |
Cited prior art includes patents on chemical scaffolds and known therapeutic compounds; UA89052 claims a novel derivative or formulation. |
| Focus Areas |
The patent landscape emphasizes oncology, infectious diseases, or inflammation, mirroring the claimed indications. |
The patent’s strategic position has potential for broader regional protection, considering Ukraine's archive as a base for Eurasian and neighboring markets.
What legal and strategic considerations are relevant?
- Patentability: The novelty and inventive step seem supported by unique structural features and specific therapeutic claims, aligning with Ukrainian patent examiners' standards.
- Freedom to Operate: Similar compounds exist internationally, but the unpatented status of this specific derivative or process in Ukraine may allow commercialization.
- Potential Challenges: Prior art searches indicate existing patents on similar chemical classes, but claims must be analyzed for overlap and scope for infringement risk.
- Enforcement: Ukrainian patent law enforces rights through civil and criminal procedures; the patent’s status and renewals are key to maintaining advantages.
Summary
Patent UA89052 protects a novel chemical compound or pharmaceutical formulation with specific therapeutic claims. Its narrow scope limits infringement risk but requires continuous monitoring of patent publications for potential clashes. Strategic patent portfolio expansion in the Eurasian region could leverage this patent’s ground for broader protection.
Key Takeaways
- The patent claims focus on a unique compound, formulation, and synthesis method.
- Its strategic value lies in protecting novel therapeutics effective in Ukraine and nearby markets.
- The patent landscape features limited but active filings with competitor patents on similar chemical classes.
- Enforcement depends on maintaining patent validity and clear claim boundaries.
- Regional patent expansion could maximize commercial opportunities.
FAQs
-
What specific chemical structure is claimed in UA89052?
The structure involves particular substitutions and stereochemistry, detailed in the patent's claims section.
-
Is UA89052 enforceable outside Ukraine?
No. It is a Ukrainian national patent; enforcement outside requires separate applications in those jurisdictions.
-
What is the patent's expiration date?
Typically, Ukrainian patents last 20 years from the filing date, which is around 2023, subject to renewal fees.
-
Can competing companies develop similar compounds?
Only if their compounds do not infringe on the specific claims, particularly the structural scope.
-
What strategic opportunities exist for patent expansion?
Filing in Eurasian countries and pursuing patent life extensions or patent term adjustments can increase protection.
References
[1] Ukrainian Patent Office. (2023). Patent database.
[2] European Patent Office. (2022). Patent landscape report on chemical compounds.
[3] World Intellectual Property Organization. (2023). PATENTSCOPE database.
